影像组学在肝细胞癌及肝硬化相关结节方面的研究进展
Research Progress of Radiomics in Hepatocellular Carcinoma and Cirrhosis-Related Nodules
DOI: 10.12677/ACM.2023.13102146, PDF,   
作者: 姚翠翠, 袁振国*：山东第一医科大学附属省立医院放射科，山东 济南
关键词: 肝细胞癌；放射组学；肝硬化相关结节分级；Hepatocellular Carcinoma； Radiomics； Cirrhosis-Related Nodule Classification
摘要: 肝细胞癌(Hepatocellular carcinoma, HCC)是危害人类生命的最常见的恶性肿瘤之一。随着医学成像技术的不断完善，人们可以早期发现病变并进行干预，为患者提供最大的生存机会。基于影像组学的最新进展，其为肝细胞癌(Hepatocellular Carcinoma, HCC)与肝硬化相关结节的准确鉴别及肝癌的早期精准诊断提供了可能性。本综述旨在分析肝硬化相关结节鉴别、肝癌的诊断、影像组学先进技术，通过对已发表文献的回顾，对肝硬化相关结节的鉴别、原发性肝癌的发展、分级、分子生物表达进行分析总结，以阐明影像组学在改善肝癌患者预后，提高患者生存率方面的作用。
Abstract: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors that harm human life. With the development of the medical imaging technology, people can detect lesions early and in-tervene which gives patients the greatest chance of survival. Based on the latest advances in radi-omics, it provides the possibility for the accurate identification of nodules associated with Hepato-cellular Carcinoma (HCC) and accurate diagnosis of liver cancer. The purpose of this review is to an-alyze the identification of cirrhosis associated nodules, the diagnosis of liver cancer, and the ad-vanced techniques of imaging radiomics. Through a review of the published literature, analyzing and summarizing the identification of cirrhosis related nodules, the development, classification and molecular biological expression of primary liver cancer, to elucidate the role of imaging radiomics in improving the prognosis and survival rate of patients with liver cancer.
文章引用：姚翠翠, 袁振国. 影像组学在肝细胞癌及肝硬化相关结节方面的研究进展[J]. 临床医学进展, 2023, 13(10): 15335-15340. https://doi.org/10.12677/ACM.2023.13102146

参考文献

[1] Jiang, L., Miao, Z., Chen, H., et al. (2023) Radiomics Analysis of Diffusion-Weighted Imaging and Long-Term Unfa-vorable Outcomes Risk for Acute Stroke. Stroke, 54, 488-498. [Google Scholar] [CrossRef] 
[2] El-Serag, H.B., Davila, J.A., Petersen, N.J., et al. (2003) The Continuing Increase in the Incidence of Hepatocellular Carcinoma in the United States: An Update. Annals of Inter-nal Medicine, 139, 817. [Google Scholar] [CrossRef] [PubMed]
[3] McGlynn, K.A. and London, W.T. (2005) Epi-demiology and Natural History of Hepatocellular Carcinoma. Best Practice & Research Clinical Gastroenterology, 19, 3-23. [Google Scholar] [CrossRef] [PubMed]
[4] Choi, B.I., Takayasu, K. and Han, M.C. (1993) Small Hepa-tocellular Carcinomas and Associated Nodular Lesions of the Liver: Pathology, Pathogenesis, and Imaging Findings. American Journal of Roentgenology, 160, 1177-1187. [Google Scholar] [CrossRef] [PubMed]
[5] Di Martino, M., Anzidei, M., Zaccagna, F., et al. (2016) Qualitative Analysis of Small (≤ 2 cm) Regenerative Nodules, Dysplastic Nodules and Well-Differentiated HCCs with Gadoxetic Acid MRI. BMC Medical Imaging, 16, Article No. 62. [Google Scholar] [CrossRef] [PubMed]
[6] Park, H.J., Choi, B.I., Lee, E.S., et al. (2018) How to Differentiate Borderline Hepatic Nodules in Hepatocarcinogenesis: Emphasis on Imaging Diagnosis. Liver Cancer, 6, 189-203. [Google Scholar] [CrossRef] [PubMed]
[7] Bruix, J. and Sherman, M. (2011) Management of Hepatocellular Carcinoma: An Update. Hepatology, 53, 1020-1022. [Google Scholar] [CrossRef] [PubMed]
[8] Jang, H.J., Kim, T.K., Burns, P.N. and Wilson, S.R. (2007) Enhancement Patterns of Hepatocellular Carcinoma at Contrast-Enhanced Us: Comparison with Histologic Differentiation. Radiology, 244, 898-906. [Google Scholar] [CrossRef] [PubMed]
[9] Li, C.S., Chen, R.C., Tu, H.Y., et al. (2006) Imaging Well-Differentiated Hepatocellular Carcinoma with Dynamic Triple-Phase Helical Computed Tomography. The British Journal of Radiology, 79, 659-665. [Google Scholar] [CrossRef] [PubMed]
[10] Park, M.S., Kim, S., Patel, J., et al. (2012) Hepatocellular Carcinoma: Detection with Diffusion-Weighted versus Contrast-Enhanced Magnetic Resonance Imaging in Pretransplant Patients. Hepatology, 56, 140-148. [Google Scholar] [CrossRef] [PubMed]
[11] Taouli, B. and Koh, D.M. (2010) Diffusion-Weighted MR Imaging of the Liver. Radiology, 254, 47-66. [Google Scholar] [CrossRef] [PubMed]
[12] Ahn, S.S., Kim, M.J., Lim, J.S., et al. (2010) Added Value of Gadoxetic Acid-Enhanced Hepatobiliary Phase MR Imaging in the Diagnosis of Hepatocellular Carcinoma. Radiology, 255, 459-466. [Google Scholar] [CrossRef] [PubMed]
[13] Kawada, N., Ohkawa, K., Tanaka, S., et al. (2010) Im-proved Diagnosis of Well-Differentiated Hepatocellular Carcinoma with Gadolinium Ethoxybenzyl Diethylene Triamine Pentaacetic Acid-Enhanced Magnetic Resonance Imaging and Sonazoid Contrast-Enhanced Ultrasonography. Hepatology Research, 40, 930-936. [Google Scholar] [CrossRef] 
[14] Jiang, H., Liu, X., Chen, J., et al. (2019) Man or Machine? Prospective Comparison of the Version 2018 EASL, LI-RADS Criteria and a Radiomics Model to Diagnose Hepatocel-lular Carcinoma. Cancer Imaging, 19, Article No. 84. [Google Scholar] [CrossRef] [PubMed]
[15] Castellano, G., Bonilha, L., Li, L.M. and Cendes, F. (2004) Tex-ture Analysis of Medical Images. Clinical Radiology, 59, 1061-1069. [Google Scholar] [CrossRef] [PubMed]
[16] Mokrane, F.Z., Lu, L., Vavasseur, A., et al. (2020) Radiomics Machine-Learning Signature for Diagnosis of Hepatocellular Carcinoma in Cirrhotic Patients with Indeterminate Liver Nodules. European Radiology, 30, 558-570. [Google Scholar] [CrossRef] [PubMed]
[17] Zhong, X., Tang, H., Lu, B., et al. (2020) Differentiation of Small Hepatocellular Carcinoma from Dysplastic Nodules in Cirrhotic Liver: Texture Analysis Based on MRI Improved Performance in Comparison over Gadoxetic Acid-En- hanced MR and Diffusion-Weighted Imaging. Frontiers in On-cology, 9, Article 1382. [Google Scholar] [CrossRef] [PubMed]
[18] Zhong, X., Li, J.S., Chen, Z.J., Yin, J.X., Gui, S., Sun, Z.Q. and Tang, H.S. (2020) [Texture Analysis of Diffusion- Weighted Magnetic Resonance Imaging to Identify Atypically En-hanced Small Hepatocellular Carcinoma and Dysplastic Nodules under the Background of Cirrhosis]. Chinese Journal of Hepatology, 28, 37-42.
[19] Zhong, X., Guan, T., Tang, D., et al. (2021) Differentiation of Small (≤ 3 cm) Hepatocellu-lar Carcinomas from Benign Nodules in Cirrhotic Liver: The Added Additive Value of MRI-Based Radiomics Analysis to LI-RADS Version 2018 Algorithm. BMC Gastroenterology, 21, Article No. 155. [Google Scholar] [CrossRef] [PubMed]
[20] 相悦. 影像组学在评估小肝癌与不典型增生结节的价值研究[D]: [硕士学位论文]. 大连: 大连医科大学, 2020.[CrossRef] 
[21] Ganesan, P. and Kulik, L.M. (2023) Hepatocellular Car-cinoma. Clinics in Liver Disease, 27, 85-102. [Google Scholar] [CrossRef] [PubMed]
[22] Wu, M., Tan, H., Gao, F., et al. (2019) Predicting the Grade of Hepatocellular Carcinoma Based on Non-Contrast- Enhanced MRI Radiomics Signature. European Radiology, 29, 2802-2811. [Google Scholar] [CrossRef] [PubMed]
[23] Zhou, W., Zhang, L., Wang, K., et al. (2017) Malig-nancy Characterization of Hepatocellular Carcinomas Based on Texture Analysis of Contrast-Enhanced MR Images. Journal of Magnetic Resonance Imaging, 45, 1476-1484. [Google Scholar] [CrossRef] [PubMed]
[24] Mao, Y., Wang, J., Zhu, Y., et al. (2022) GD-EOB-DTPA-Enhanced MRI Radiomic Features for Predicting Histological Grade of Hepatocellular Carcinoma. Hepatobiliary Surgery and Nutrition, 11, 13-24. [Google Scholar] [CrossRef] [PubMed]
[25] Feng, M., Zhang, M., Liu, Y., et al. (2020) Texture Analysis of MR Images to Identify the Differentiated Degree in Hepatocellular Carcinoma: A Retrospective Study. BMC Cancer, 20, Ar-ticle No. 611. [Google Scholar] [CrossRef] [PubMed]
[26] Choi, J.M., Yu, J.S., Cho, E.S., et al. (2020) Texture Analysis of Hepatocellular Carcinoma on Magnetic Resonance Imaging: Assessment for Performance in Predicting Histopathologic Grade. Journal of Computer Assisted Tomography, 44, 901-910. [Google Scholar] [CrossRef] 
[27] Geng, Z., Zhang, Y., Wang, S., et al. (2021) Radiomics Analysis of Susceptibility Weighted Imaging for Hepatocellular Carcinoma: Exploring the Correlation between Histo-pathology and Radiomics Features. Magnetic Resonance in Medical Sciences, 20, 253-263. [Google Scholar] [CrossRef] [PubMed]
[28] 赵莹, 刘爱连, 武敬君, 郭妍, 宋清伟, 李昕, 吴艇帆, 崔景景. 基于增强MRI影像组学术前预测肝细胞癌病理分化程度[J]. 中国医学影像学杂志, 2021, 29(6): 570-576.
[29] Brancato, V., Garbino, N., Salvatore, M. and Cavaliere, C. (2022) MRI-Based Radiomic Features Help Identify Lesions and Predict Histopathological Grade of Hepatocellular Carcinoma. Diagnostics, 12, Article 1085. [Google Scholar] [CrossRef] [PubMed]
[30] Han, Y.E., Cho, Y., Kim, M.J., et al. (2022) Hepatocellular Car-cinoma Pathologic Grade Prediction Using Radiomics and Machine Learning Models of Gadoxetic Acid-Enhanced MRI: A Two-Center Study. Abdominal Radiology, 48, 244-256.
https://link.springer.com/10.1007/s00261-022-03679-y
[31] Feng, Z., Li, H., Liu, Q., et al. (2023) CT Radiomics to Predict Macrotrabecular-Massive Subtype and Immune Status in Hepatocellular Carcinoma. Radiology, 307, e221291. [Google Scholar] [CrossRef] [PubMed]
[32] Wu, H., Han, X., Wang, Z., et al. (2020) Prediction of the Ki-67 Marker Index in Hepatocellular Carcinoma Based on CT Radiomics Features. Physics in Medicine & Biology, 65, Article ID: 235048. [Google Scholar] [CrossRef] [PubMed]
[33] Wu, C., Chen, J., Fan, Y., et al. (2022) Nomogram Based on CT Radiomics Features Combined with Clinical Factors to Predict Ki-67 Expression in Hepatocellular Carcinoma. Frontiers in Oncology, 12, Article 943942. [Google Scholar] [CrossRef] [PubMed]
[34] Ye, Z., Jiang, H., Chen, J., et al. (2019) Texture Analysis on Gadoxetic Acid Enhanced-MRI for Predicting Ki-67 Status in Hepatocellular Carcinoma: A Prospective Study. Chinese Journal of Cancer Research, 31, 806-817. [Google Scholar] [CrossRef] [PubMed]
[35] Li, Y., Yan, C., Weng, S., et al. (2019) Texture Analy-sis of Multi-Phase MRI Images to Detect Expression of Ki67 in Hepatocellular Carcinoma. Clinical Radiology, 74, 813.e19-813.e27.
[36] Fan, Y., Yu, Y., Wang, X., Hu, M.J. and Hu, C.H. (2021) Radiomic Analysis of GD-EOB-DTPA-Enhanced MRI Predicts Ki-67 Expression in Hepatocellular Carcinoma. BMC Medical Imaging, 21, Article No. 100. [Google Scholar] [CrossRef] [PubMed]

为你推荐